AEOI expanding cold plasma, radiopharma tech for medical use
Iran has equipped around 10 centers with cold plasma technology, a novel medical tool already in use in advanced countries, the head of the Atomic Energy Organization of Iran (AEOI) Mohammad Eslami said on Tuesday.
“Cold plasma is a new technology in advanced countries, and Iran is proud to move faster and more decisively to put its capabilities at the service of society,” Eslami said. “Today we too, alongside these countries, are expanding and developing this technology, especially in the field of cancer and treatment of malignant wounds,” Tasnim quoted him as saying.
The vice president added that so far more than 70 types of radiopharmaceuticals are supplied to nuclear medicine centers across Iran, benefiting over 220 facilities nationwide. “The remarkable point is that these radiopharmaceuticals have been developed in three areas: diagnostic, palliative and therapeutic,” the AEOI head said.
Eslami noted that in diagnostics, advances in the field are helping improve accuracy so that doctors can “better identify the patient’s body environment.” In the therapeutic field, he said, efforts were focused on reducing patients’ pain and suffering while providing effective treatments.
About 20 additional radiopharmaceuticals are currently in research and clinical testing stages, he added.